GB0619325D0 - New compounds - Google Patents

New compounds

Info

Publication number
GB0619325D0
GB0619325D0 GBGB0619325.4A GB0619325A GB0619325D0 GB 0619325 D0 GB0619325 D0 GB 0619325D0 GB 0619325 A GB0619325 A GB 0619325A GB 0619325 D0 GB0619325 D0 GB 0619325D0
Authority
GB
United Kingdom
Prior art keywords
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0619325.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Strathclyde
Original Assignee
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Strathclyde filed Critical University of Strathclyde
Priority to GBGB0619325.4A priority Critical patent/GB0619325D0/en
Publication of GB0619325D0 publication Critical patent/GB0619325D0/en
Priority to DK07823959.7T priority patent/DK2066627T3/da
Priority to JP2009529767A priority patent/JP5564257B2/ja
Priority to CA2664847A priority patent/CA2664847C/en
Priority to GB0906908A priority patent/GB2455479C/en
Priority to HK10105059.5A priority patent/HK1138281B/xx
Priority to PL07823959T priority patent/PL2066627T3/pl
Priority to EP07823959.7A priority patent/EP2066627B1/en
Priority to ES07823959.7T priority patent/ES2443720T3/es
Priority to CN200780043350.4A priority patent/CN101589024B/zh
Priority to US12/443,529 priority patent/US8012967B2/en
Priority to PCT/GB2007/003698 priority patent/WO2008038018A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB0619325.4A 2006-09-30 2006-09-30 New compounds Ceased GB0619325D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB0619325.4A GB0619325D0 (en) 2006-09-30 2006-09-30 New compounds
PCT/GB2007/003698 WO2008038018A1 (en) 2006-09-30 2007-09-28 Novel minor groove binders
GB0906908A GB2455479C (en) 2006-09-30 2007-09-28 Novel minor groove binders
JP2009529767A JP5564257B2 (ja) 2006-09-30 2007-09-28 新規副溝バインダー
CA2664847A CA2664847C (en) 2006-09-30 2007-09-28 Novel minor groove binders
DK07823959.7T DK2066627T3 (da) 2006-09-30 2007-09-28 Nye mindre fure (minor groove) bindemidler
HK10105059.5A HK1138281B (en) 2006-09-30 2007-09-28 Minor groove binders
PL07823959T PL2066627T3 (pl) 2006-09-30 2007-09-28 Nowe środki wiążące mały rowek
EP07823959.7A EP2066627B1 (en) 2006-09-30 2007-09-28 Novel minor groove binders
ES07823959.7T ES2443720T3 (es) 2006-09-30 2007-09-28 Nuevos compuestos de unión al surco menor
CN200780043350.4A CN101589024B (zh) 2006-09-30 2007-09-28 小沟结合物
US12/443,529 US8012967B2 (en) 2006-09-30 2007-09-28 Minor groove binders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0619325.4A GB0619325D0 (en) 2006-09-30 2006-09-30 New compounds

Publications (1)

Publication Number Publication Date
GB0619325D0 true GB0619325D0 (en) 2006-11-08

Family

ID=37434989

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0619325.4A Ceased GB0619325D0 (en) 2006-09-30 2006-09-30 New compounds
GB0906908A Expired - Fee Related GB2455479C (en) 2006-09-30 2007-09-28 Novel minor groove binders

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0906908A Expired - Fee Related GB2455479C (en) 2006-09-30 2007-09-28 Novel minor groove binders

Country Status (10)

Country Link
US (1) US8012967B2 (https=)
EP (1) EP2066627B1 (https=)
JP (1) JP5564257B2 (https=)
CN (1) CN101589024B (https=)
CA (1) CA2664847C (https=)
DK (1) DK2066627T3 (https=)
ES (1) ES2443720T3 (https=)
GB (2) GB0619325D0 (https=)
PL (1) PL2066627T3 (https=)
WO (1) WO2008038018A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9072535B2 (en) 2011-05-27 2015-07-07 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with rotatable staple deployment arrangements
US8969349B2 (en) * 2010-05-26 2015-03-03 Sunovion Pharmaceuticals Inc. Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors
CZ305332B6 (cs) * 2013-10-25 2015-08-05 Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové Použití derivátů pyrazinu a jejich isosterů jako sloučenin vážících se do malého žlábku DNA
CN105732583B (zh) * 2016-03-25 2018-05-04 苏州麦迪耐斯医药科技有限公司 一种治疗脑胶质母细胞瘤的靶向化合物
JP7072557B2 (ja) 2016-07-22 2022-05-20 ブリストル－マイヤーズ スクイブ カンパニー グルコキナーゼ活性化剤およびその使用方法
WO2018047148A1 (en) 2016-09-12 2018-03-15 Novartis Ag Compounds for the inhibition of mirna
JP7477858B2 (ja) * 2020-03-05 2024-05-02 国立大学法人電気通信大学 急性ｔリンパ芽球性白血病若しくはリンパ腫、又は急性骨髄性白血病治療用医薬組成物
GB202114032D0 (en) 2021-09-30 2021-11-17 Univ Strathclyde Antivirals
GB202206931D0 (en) 2022-05-12 2022-06-29 Univ Strathclyde Compounds
CN115109113B (zh) * 2022-05-31 2023-06-27 上海应用技术大学 一种胆固醇类衍生物有机凝胶因子及其制备方法和应用
CN116514698A (zh) * 2023-04-10 2023-08-01 佛山奕安赛医药科技有限公司 一种沃诺拉赞中间体的制备方法及其应用

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1886481A (en) * 1927-11-07 1932-11-08 Soc Of Chemical Ind Unilaterally acylated diamines and process of making same
DE2331444A1 (de) 1973-06-20 1975-01-23 Hoechst Ag Neue styryl-benzoxazole, verfahren zu deren herstellung und ihre verwendung als optische aufhellungsmittel
US4665181A (en) 1984-05-17 1987-05-12 Pennwalt Corporation Anti-inflammatory phthalazinones
CA1308516C (en) * 1987-07-06 1992-10-06 The Governors Of The University Of Alberta Oligopeptide anticancer and antiviral agents
IL90337A0 (en) 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
US4919199A (en) * 1989-01-13 1990-04-24 The Atlantic Group, Inc. Multiple locking stake for tube bundle
FR2656608B1 (fr) 1989-12-28 1992-04-24 Roussel Uclaf Nouvelles polyamines benzoylees, leur procede de preparation et leur application comme fongicides.
US5273991A (en) * 1992-07-29 1993-12-28 Research Corporation Technologies, Inc. Imidazole-containing compositions and methods of use thereof analogs of distamycin
IT1263089B (it) * 1993-04-26 1996-07-24 Menarini Farma Ind Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
US5698674A (en) * 1994-04-13 1997-12-16 The Regents Of The University Of California Triheterocyclic peptides capable of binding the minor and major grooves of DNA
GB9416005D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5637621A (en) * 1994-11-14 1997-06-10 Nzym, Inc. Methods and compositions for treating Botrytis infections
US5801155A (en) * 1995-04-03 1998-09-01 Epoch Pharmaceuticals, Inc. Covalently linked oligonucleotide minor grove binder conjugates
US5767142A (en) * 1996-03-20 1998-06-16 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
GB9516943D0 (en) * 1995-08-18 1995-10-18 Cancer Soc Auckland Div Nz Inc Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
JP2000503999A (ja) 1996-02-02 2000-04-04 フアルマシア・エ・アツプジヨン・エツセ・ピー・アー ジスタマイシン誘導体、その調製方法、および抗腫瘍および抗ウイルス剤としてのその使用
US6506906B1 (en) * 1996-02-26 2003-01-14 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
US6143901A (en) * 1996-07-31 2000-11-07 Genesoft, Inc. Complex formation between dsDNA and pyrrole imidazole polyamides
US6090947A (en) * 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
EP0968186A1 (en) * 1996-02-26 2000-01-05 California Institute Of Technology Improved polyamides for binding in the minor groove of double stranded dna
US6635417B1 (en) * 1996-07-31 2003-10-21 California Institute Of Technology Complex formation between DSDNA and oligomer of cyclic heterocycles
US5770617A (en) 1996-03-20 1998-06-23 Rutgers, The State University Of New Jersey Terbenzimidazoles useful as antifungal agents
EP0934269A4 (en) * 1996-05-31 2000-01-12 Scripps Research Inst ANALOGS OF CC-1065 AND DUOCARMYCINE
AU735648B2 (en) * 1996-07-12 2001-07-12 Ariad Pharmaceuticals, Inc. Materials and method for treating or preventing pathogenic fungal infection
US6660255B1 (en) * 1996-08-01 2003-12-09 California Institute Of Technology Inhibition of gene transcription by polyamide DNA-binding ligands
GB9623522D0 (en) 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
US6251933B1 (en) * 1996-12-13 2001-06-26 The Cancer Research Campaign Technology Limited Seco precursors of cyclopropylindolines and their use as prodrugs
US6221589B1 (en) * 1997-07-17 2001-04-24 Tm Technologies, Inc. Methods and compositions for modulating melting temperatures of nucleic acids
JPH11189594A (ja) 1997-12-25 1999-07-13 Mitsui Chem Inc アクリル酸誘導体を側鎖にもつピロリルベンズイミダゾール誘導体
US6008247A (en) * 1998-02-27 1999-12-28 The University Of North Carolina At Chapel Hill 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents
AU758563B2 (en) * 1998-08-20 2003-03-27 University Of North Carolina At Chapel Hill, The Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
GB9818731D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Compounds
DE69925133T2 (de) 1998-08-27 2006-01-19 Spirogen Ltd., Ryde Pyrrolobenzodiazepine
GB9818730D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
ES2275362T3 (es) * 1998-09-17 2007-06-01 The University Of North Carolina At Chapel Hill Actividad antifungica de moleculas dicationicas.
GB9908828D0 (en) * 1999-04-16 1999-06-16 Univ Reading The Compounds
ES2282127T3 (es) * 1999-07-08 2007-10-16 University Of North Carolina At Chapel Hill Nuevos profarmacos para amidinas anticrobianas.
WO2001019792A1 (en) 1999-09-17 2001-03-22 Genelabs Technologies, Inc. Covalently linked dimeric dna binding molecules
CA2392150A1 (en) * 1999-12-20 2001-06-28 The University Of North Carolina At Chapel Hill Diamidine compounds as dna minor groove binders
JP2001181279A (ja) 1999-12-28 2001-07-03 Mitsui Chemicals Inc ベンゾフラニルピロールカルボキシアミド誘導体
CA2403537A1 (en) * 2000-03-16 2001-10-11 Genesoft, Inc. Charged compounds comprising a nucleic acid binding moiety and uses therefor
AU2001262974A1 (en) 2000-05-03 2001-11-12 The Scripps Research Institute Dna alkylating agent and activation thereof
AU2001269885A1 (en) 2000-06-14 2001-12-24 The Scripps Research Institute Distamycin a analogs
KR20030011371A (ko) 2000-06-27 2003-02-07 진랩스 테크놀러지스, 인크. 항세균, 항진균 또는 항암 활성을 갖는 신규 화합물
GB0015904D0 (en) 2000-06-28 2000-08-23 Hoffmann La Roche Inhibitors of HPV E1 helicase enzyme
AU2001282070A1 (en) * 2000-07-11 2002-01-21 Universite De Geneve Linked, sequence-specific DNA-binding molecules
WO2002030894A2 (en) * 2000-09-19 2002-04-18 Taiho Pharmaceutical Co., Ltd. Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
WO2002095022A2 (en) 2001-05-21 2002-11-28 Universite De Geneve Sequence-specific dna binding compounds and their use in targeting telomeres and other dna sequences
US20030236198A1 (en) 2001-06-13 2003-12-25 Genesoft, Inc. Antipathogenic benzamide compounds
CA2450625A1 (en) 2001-06-13 2002-12-19 Genesoft Pharmaceuticals, Inc. Isoquinoline compounds having antiinfective activity
JP2003089652A (ja) 2001-09-20 2003-03-28 Meiji Seika Kaisha Ltd 抗口腔カンジダ症組成物
US20030187026A1 (en) * 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
WO2003070450A1 (en) 2002-02-21 2003-08-28 Riken High-strength film of polyhydroxyalkanoic acid and process for producing the same
AU2003217782A1 (en) 2002-02-27 2003-09-09 The Government Of The United States Of America, Representated By The Secretary, Deparment Of Health Dna-binding polyamide drug conjugates
AU2003213836A1 (en) 2002-03-11 2003-09-29 Epoch Biosciences, Inc. Negatively charged minor groove binders
AU2004260756B2 (en) 2003-07-30 2010-03-25 Kyowa Hakko Kirin Co., Ltd. Indazole derivatives

Also Published As

Publication number Publication date
CA2664847C (en) 2014-12-02
WO2008038018A1 (en) 2008-04-03
EP2066627A1 (en) 2009-06-10
PL2066627T3 (pl) 2014-05-30
CN101589024A (zh) 2009-11-25
GB2455479B (en) 2009-10-28
CA2664847A1 (en) 2008-04-03
CN101589024B (zh) 2014-01-01
EP2066627B1 (en) 2013-10-23
JP5564257B2 (ja) 2014-07-30
ES2443720T3 (es) 2014-02-20
US20100016311A1 (en) 2010-01-21
GB2455479A (en) 2009-06-17
DK2066627T3 (da) 2014-01-27
GB2455479C (en) 2012-05-16
HK1138281A1 (en) 2010-08-20
US8012967B2 (en) 2011-09-06
JP2010505757A (ja) 2010-02-25
GB0906908D0 (en) 2009-06-03

Similar Documents

Publication Publication Date Title
IL226046A0 (en) new compounds
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
EP1984379A4 (en) ANTI-ARENAVIRAL COMPOUNDS
GB0605786D0 (en) Compounds
GB0606876D0 (en) Compounds
EP2082022A4 (en) COMPOUNDS
GB0619325D0 (en) New compounds
EP2004174A4 (en) NAPHTHALENEDIONED COMPOUNDS
GB0605784D0 (en) Compounds
GB0606913D0 (en) Compounds
GB0602042D0 (en) Compounds
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
GB0625826D0 (en) New compounds
EP1973905A4 (en) COMPOUNDS
GB0625827D0 (en) New compounds
GB0600427D0 (en) Compounds
HU0600920D0 (en) New compounds
HU0600726D0 (en) New compounds
HU0600918D0 (en) New compounds
HU0600919D0 (en) New compounds
GB0611836D0 (en) New compounds
GB0603132D0 (en) Compounds
GB0602451D0 (en) Compounds
GB0602454D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)